speb/financial-data huggingface dataset:
Financial ratios for AQN.TO — annual report dated 2024-12-31
Total revenue: 1622027972.027972
Gross profit: 1201888111.8881118
Operating income: 314405594.4055944
Net income: -965384615.3846154
Capital expenditures: 610069930.0699301
Operating cash flow: 336853146.85314685
Depreciation & amortization: 333356643.3566434
Net tangible assets: 2326293706.2937064
Owner earnings: -1242097902.097902
Return on net tangible assets (%): -53.39385558828834
Capex to operating income (%): 194.0391459074733
Buffett classification: The Gruesome
Stock price: 4.167832167832168
Shares outstanding: 769665544
Book value: 4322517482.517484
P/B ratio: 0.7421223455380831
Market cap (USD): 3207836812.755245
Debt to equity: 1.083721607454863
Current ratio: 0.7579966611018363
Quick ratio: 0.6086811352253756
Effective tax rate (%): 105.41760722347631
Interest coverage ratio: 1.1548933984073977
COGS to revenue (%): 25.902134080620826
Free cash flow (dilution-adjusted): -286083916.08391607
Buyback yield (%): 0
Retained earnings: -2048881118.881119
Inventory turnover: 2.6869409660107335
Receivables turnover: 5.488641741599621
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.907360225553213
FCF margin (%): -17.637421858159087
Revenue growth (%): -10.93408431061368
Rule of 40 score: -28.571506168772764
Financial ratios for AQN.TO — quarterly report dated 2025-03-31
Total revenue: 484195804.19580424
Gross profit: 335454545.4545455
Operating income: 127832167.83216783
Net income: 67692307.6923077
Capital expenditures: 155664335.66433567
Operating cash flow: 51678321.67832168
Depreciation & amortization: 66643356.64335664
Net tangible assets: 2314405594.4055943
Owner earnings: -21328671.328671336
Return on net tangible assets (%): -0.9215615180082188
Capex to operating income (%): 121.77242888402627
Buffett classification: The Gruesome
Stock price: 4.888111888111888
P/E ratio: 13.89453035268595
Shares outstanding: 769665544
Book value: 3601118881.118881
P/B ratio: 1.044733989544819
Market cap (USD): 3762211295.496504
Debt to equity: 1.2276681684014292
Current ratio: 1.1605003710378459
Quick ratio: 0.9375596310823704
Effective tax rate (%): 20.349434737923943
Interest coverage ratio: 2.3197969543147208
COGS to revenue (%): 30.71923743500866
Free cash flow (dilution-adjusted): -106153846.15384616
Buyback yield (%): 0
Retained earnings: -2018321678.3216784
Inventory turnover: 1.0114122681883022
Receivables turnover: 1.3239005736137668
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.437106918238994
FCF margin (%): -21.92374350086655
Rule of 40 score: -21.92374350086655
Financial ratios for AQN.TO — quarterly report dated 2025-06-30
Total revenue: 385255474.4525547
Gross profit: 294306569.3430657
Operating income: 57518248.17518248
Net income: 17591240.875912406
Capital expenditures: 135620437.95620435
Operating cash flow: 182408759.12408757
Depreciation & amortization: 78102189.7810219
Net tangible assets: 2404233576.6423354
Owner earnings: -39927007.29927006
Return on net tangible assets (%): -1.6606958528143783
Capex to operating income (%): 235.7868020304568
Buffett classification: The Gruesome
Stock price: 5.437956204379562
P/E ratio: 49.076376283099606
Shares outstanding: 769665544
Book value: 3741751824.8175173
P/B ratio: 1.1185689795169913
Market cap (USD): 4185407520.2919707
Debt to equity: 1.2345987281026884
Current ratio: 1.0927924039706518
Quick ratio: 0.8617824773413898
Effective tax rate (%): 109.375
Interest coverage ratio: 1.0167741935483872
COGS to revenue (%): 23.607427055702917
Free cash flow (dilution-adjusted): 44890510.94890511
Buyback yield (%): 0
Retained earnings: -2127810218.978102
Inventory turnover: 0.5819710415693601
Receivables turnover: 1.0986677768526227
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6172355991415099
FCF margin (%): 11.652140962485792
Revenue growth (%): -20.433950250266726
Rule of 40 score: -8.781809287780934
Financial ratios for AQN.TO — quarterly report dated 2025-09-30
Total revenue: 419208633.09352523
Gross profit: 328345323.7410072
Operating income: 106043165.4676259
Net income: 27985611.51079137
Capital expenditures: 108489208.63309354
Operating cash flow: 70935251.79856116
Depreciation & amortization: 68129496.4028777
Net tangible assets: 2344820143.8848925
Owner earnings: -12374100.719424456
Return on net tangible assets (%): -0.5277206762188198
Capex to operating income (%): 102.30664857530529
Buffett classification: The Gruesome
Stock price: 5.20863309352518
P/E ratio: 35.39273550389204
Shares outstanding: 769665544
Book value: 3650503597.122302
P/B ratio: 1.0981787352804384
Market cap (USD): 4008905423.424461
Debt to equity: 1.2681013755862995
Current ratio: 1.2274673517448085
Quick ratio: 0.9849068721901093
Effective tax rate (%): 31.505250875145858
Interest coverage ratio: 1.86346396965866
COGS to revenue (%): 21.67496138664836
Free cash flow (dilution-adjusted): -40143884.892086335
Buyback yield (%): 0
Retained earnings: -2107410071.9424462
Inventory turnover: 0.557369814651368
Receivables turnover: 1.0668253387037716
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1467069129156227
FCF margin (%): -9.576111206452719
Revenue growth (%): 8.813154099683523
Rule of 40 score: -0.7629571067691963
Financial ratios for AQN.TO — annual report dated 2025-12-31
Total revenue: 1776350364.9635036
Gross profit: 1309343065.6934307
Operating income: 381824817.51824814
Net income: 131970802.91970801
Capital expenditures: 563430656.9343065
Operating cash flow: 433284671.5328467
Depreciation & amortization: 292189781.0218978
Net tangible assets: 2373211678.8321166
Owner earnings: -139270072.9927007
Return on net tangible assets (%): -5.8684218620244195
Capex to operating income (%): 147.56260753202065
Buffett classification: The Gruesome
Stock price: 6.02919708029197
P/E ratio: 35.16281744159292
Shares outstanding: 769665544
Book value: 3684890510.948905
P/B ratio: 1.2593224240714695
Market cap (USD): 4640465250.6861315
Debt to equity: 1.2940791949765267
Current ratio: 1.0043373092001
Quick ratio: 0.8154141296188172
Effective tax rate (%): 30.80568720379147
Interest coverage ratio: 1.6569528032942666
COGS to revenue (%): 26.290269559500327
Free cash flow (dilution-adjusted): -139635036.49635035
Buyback yield (%): 0
Retained earnings: -2161532846.715328
Inventory turnover: 2.824724061810154
Receivables turnover: 4.918350848827809
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.043347530010125
FCF margin (%): -7.860782380013148
Revenue growth (%): 9.514163479103695
Rule of 40 score: 1.6533810990905469
Financial ratios for AQN.TO — quarterly report dated 2025-12-31
Total revenue: 460364963.5036496
Gross profit: 326131386.8613138
Operating income: 83284671.5328467
Net income: 15328467.15328467
Capital expenditures: 160656934.30656934
Operating cash flow: 128467153.28467153
Depreciation & amortization: 75401459.85401459
Net tangible assets: 2373211678.8321166
Owner earnings: -69927007.29927008
Return on net tangible assets (%): -2.9465137022114236
Capex to operating income (%): 192.90096406660825
Buffett classification: The Gruesome
Stock price: 6.02919708029197
P/E ratio: 36.08515452857998
Shares outstanding: 769665544
Book value: 3684890510.948905
P/B ratio: 1.2593224240714695
Market cap (USD): 4640465250.6861315
Debt to equity: 1.2940791949765267
Current ratio: 1.0043373092001
Quick ratio: 0.8154141296188172
Effective tax rate (%): 51.85185185185185
Interest coverage ratio: 1.088740458015267
COGS to revenue (%): 29.15807832566989
Free cash flow (dilution-adjusted): -34890510.94890511
Buyback yield (%): 0
Retained earnings: -2161532846.715328
Inventory turnover: 0.8119205298013243
Receivables turnover: 1.274656426839127
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.8819460010976015
FCF margin (%): -7.578880608847313
Revenue growth (%): 9.817624724570596
Rule of 40 score: 2.238744115723283
Financial ratios for AXG — annual report dated 2024-03-31
Total revenue: 551724.1379310344
Gross profit: 397190.2937420179
Operating income: -561685.8237547893
Net income: -581864.6232439335
Capital expenditures: 18007.66283524904
Operating cash flow: -716091.9540229884
Depreciation & amortization: 3831.417624521073
Net tangible assets: 1129885.0574712644
Owner earnings: -596040.8684546616
Return on net tangible assets (%): -52.75234542782864
Buffett classification: The Gruesome
Stock price: 6.22
Shares outstanding: 159082228
Book value: 1139719.0293742018
P/B ratio: 868.1889418862394
Market cap (USD): 989491458.16
Debt to equity: 0.11990138951142985
Current ratio: 2.1190791652865184
Quick ratio: 2.1190791652865184
COGS to revenue (%): 28.009259259259263
SG&A to revenue (%): 135.1851851851852
Free cash flow (dilution-adjusted): -1223243.9335887611
Buyback yield (%): 0
Retained earnings: -764240.1021711366
Receivables turnover: 1.0404624277456647
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -46.97212431912849
FCF margin (%): -221.71296296296296
Revenue growth (%): -2.738951655993251
Rule of 40 score: -224.4519146189562
Financial ratios for AXG — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 757142.8571428572
Buffett classification: The Gruesome
Stock price: 2.93
Shares outstanding: 159082228
Book value: 773745.1737451737
P/B ratio: 602.408834143513
Market cap (USD): 466110928.04
Debt to equity: 0.12142381902860945
Current ratio: 1.5146292004634994
Quick ratio: 1.5146292004634994
Buyback yield (%): 0
Retained earnings: -1575160.8751608753
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AXG — annual report dated 2025-03-31
Total revenue: 368251.92802056554
Gross profit: 20565.552699228792
Operating income: -1076606.6838046273
Net income: -1097429.3059125964
Capital expenditures: 11311.053984575836
Operating cash flow: -135861.1825192802
Depreciation & amortization: 12724.935732647815
Net tangible assets: 597043.7017994858
Owner earnings: -1096015.4241645245
Return on net tangible assets (%): -183.5737351991389
Buffett classification: The Gruesome
Stock price: 1.59
Shares outstanding: 159082228
Book value: 608097.6863753214
P/B ratio: 415.95412741610653
Market cap (USD): 252940742.52
Debt to equity: 0.22828154724159797
Current ratio: 1.288630904723779
Quick ratio: 1.288630904723779
Interest coverage ratio: -1675.2
COGS to revenue (%): 94.4153577661431
SG&A to revenue (%): 238.74345549738223
Free cash flow (dilution-adjusted): -576349.6143958869
Buyback yield (%): 0
Retained earnings: -1866580.976863753
Receivables turnover: 10.494505494505495
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -173.99252181138348
FCF margin (%): -156.50959860383944
Revenue growth (%): -33.254338046272494
Rule of 40 score: -189.76393665011193
Financial ratios for AXG — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 597043.7017994858
Buffett classification: The Gruesome
Stock price: 1.59
Shares outstanding: 159082228
Book value: 608097.6863753214
P/B ratio: 415.95412741610653
Market cap (USD): 252940742.52
Debt to equity: 0.22828154724159797
Current ratio: 1.288630904723779
Quick ratio: 1.288630904723779
Buyback yield (%): 0
Retained earnings: -1866580.976863753
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BANL — annual report dated 2023-12-31
Total revenue: 94554819.52277656
Gross profit: 1564235.3579175703
Operating income: 360483.0802603037
Net income: 247120.60737527112
Capital expenditures: 167866.16052060737
Operating cash flow: -2176324.078091106
Depreciation & amortization: 68050.75921908893
Net tangible assets: 5487998.915401301
Owner earnings: 147305.20607375266
Return on net tangible assets (%): 2.684133294202395
Capex to operating income (%): 46.56700125825372
Buffett classification: The Good
Stock price: 19.11
P/E ratio: 84.9039623317937
Shares outstanding: 1097934
Book value: 5486582.646420823
P/B ratio: 3.824150676685297
Market cap (USD): 20981518.74
Debt to equity: 0.014712839596940612
Current ratio: 1.8633799294061437
Quick ratio: 1.8633799294061437
Effective tax rate (%): 20.86315855665133
Interest coverage ratio: 5.49389723821929
COGS to revenue (%): 98.3456841588696
SG&A to revenue (%): 1.2730734231556589
Free cash flow (dilution-adjusted): -2344190.2386117135
Buyback yield (%): 0
Retained earnings: 2768131.8872017353
Receivables turnover: 16.10613827023973
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.520159926119135
FCF margin (%): -2.4791864131759462
Revenue growth (%): -9.715564226933237
Rule of 40 score: -12.194750640109184
Financial ratios for BANL — annual report dated 2024-12-31
Total revenue: 132851467.48878925
Gross profit: 1205078.9237668163
Operating income: -746096.4125560538
Net income: -837669.730941704
Capital expenditures: 32386.995515695067
Operating cash flow: -435698.65470852016
Depreciation & amortization: 118282.95964125561
Net tangible assets: 5136472.64573991
Owner earnings: -751773.7668161434
Return on net tangible assets (%): -14.635992804121129
Buffett classification: The Gruesome
Stock price: 13.13
Shares outstanding: 1097934
Book value: 5104648.65470852
P/B ratio: 2.8240677067368436
Market cap (USD): 14415873.420000002
Debt to equity: 0.06830127976640303
Current ratio: 1.4700006341187373
Quick ratio: 1.4700006341187373
Interest coverage ratio: -5.622277640920626
COGS to revenue (%): 99.09291259890034
SG&A to revenue (%): 1.4686893364482563
Free cash flow (dilution-adjusted): -468085.65022421523
Buyback yield (%): 0
Retained earnings: 2023560.7623318385
Receivables turnover: 15.300997605832771
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -14.593353338222064
FCF margin (%): -0.3523375835225267
Revenue growth (%): 40.50205812807639
Rule of 40 score: 40.149720544553865
Financial ratios for BANL — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 5136472.64573991
Buffett classification: The Gruesome
Stock price: 13.13
Shares outstanding: 1097934
Book value: 5104648.65470852
P/B ratio: 2.8240677067368436
Market cap (USD): 14415873.420000002
Debt to equity: 0.06830127976640303
Current ratio: 1.4700006341187373
Quick ratio: 1.4700006341187373
Buyback yield (%): 0
Retained earnings: 2023560.7623318385
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BANL — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 5174078.723404255
Buffett classification: The Gruesome
Stock price: 11.99
Shares outstanding: 1097934
Book value: 5174078.723404255
P/B ratio: 2.5442652429027355
Market cap (USD): 13164228.66
Debt to equity: 0.004576002223851548
Current ratio: 1.5364328065284705
Quick ratio: 1.5364328065284705
Buyback yield (%): 0
Retained earnings: 1903589.5981087468
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CA1.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -14897916.666666668
Buffett classification: The Gruesome
Stock price: 26.25
Shares outstanding: 23788202
Book value: 3129166.666666668
P/B ratio: 199.55482370173095
Market cap (USD): 624440302.5
Debt to equity: 3.044940079893474
Current ratio: 0.5359116022099447
Quick ratio: 0.49343922651933697
Buyback yield (%): 0
Retained earnings: -21364583.333333336
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CA1.DE — annual report dated 2024-12-31
Total revenue: 261458.33333333334
Gross profit: 756250
Operating income: -15558333.333333334
Net income: -15863541.666666668
Capital expenditures: 13541.666666666668
Operating cash flow: -7212500
Depreciation & amortization: 3331250
Net tangible assets: -14897916.666666668
Owner earnings: -12545833.333333334
Buffett classification: The Gruesome
Stock price: 26.25
Shares outstanding: 23788202
Book value: 3129166.666666668
P/B ratio: 199.55482370173095
Market cap (USD): 624440302.5
Debt to equity: 3.044940079893474
Current ratio: 0.5359116022099447
Quick ratio: 0.49343922651933697
Interest coverage ratio: -125.5126050420168
COGS to revenue (%): -189.24302788844622
Free cash flow (dilution-adjusted): -9506250
Buyback yield (%): 0
Retained earnings: -21364583.333333336
Inventory turnover: -3.861788617886179
Receivables turnover: 27.88888888888889
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -89.3034379671151
FCF margin (%): -3635.856573705179
Revenue growth (%): -62.88446372239746
Rule of 40 score: -3698.7410374275764
Financial ratios for CA1.DE — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -6964705.882352942
Buffett classification: The Gruesome
Stock price: 17.058823529411764
Shares outstanding: 23788202
Book value: 12924705.88235294
P/B ratio: 31.39713535408702
Market cap (USD): 405798740
Debt to equity: 0.8408884034225379
Current ratio: 7.161545215100966
Quick ratio: 6.914837576821773
Buyback yield (%): 0
Retained earnings: -36668235.294117644
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAE.TO — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 26.032
Shares outstanding: 321579686
Market cap (USD): 8371362385.952
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAE.TO — annual report dated 2023-03-31
Total revenue: 2970814814.8148146
Gross profit: 802592592.5925926
Operating income: 333111111.1111111
Net income: 171777777.77777776
Capital expenditures: 217185185.18518516
Operating cash flow: 302518518.5185185
Depreciation & amortization: 253481481.48148146
Net tangible assets: 338444444.4444444
Owner earnings: 208074074.07407406
Return on net tangible assets (%): 61.479536003501856
Capex to operating income (%): 65.19902156993551
Buffett classification: The Good
Stock price: 22.637037037037036
P/E ratio: 42.37807332539889
Shares outstanding: 321579686
Book value: 3399185185.1851845
P/B ratio: 2.1415753675521367
Market cap (USD): 7279611262.34074
Debt to equity: 0.7082525223909871
Current ratio: 0.9947923621311257
Quick ratio: 0.7351226242934081
Effective tax rate (%): 21.409028727770178
Interest coverage ratio: 2.972240581625909
COGS to revenue (%): 72.98409215578717
R&D to revenue (%): 3.216476337705082
SG&A to revenue (%): 12.58664538971725
Free cash flow (dilution-adjusted): -17037037.037037037
Buyback yield (%): 0
Retained earnings: 1522074074.074074
Inventory turnover: 5.017312307164895
Receivables turnover: 2.9537487111503906
Capitalized R&D asset: 95555555.55555555
ROCI (R&D-adjusted, %): 6.43963071596865
FCF margin (%): -0.5734802772652471
Rule of 40 score: -0.5734802772652471
Financial ratios for CAE.TO — annual report dated 2024-03-31
Total revenue: 3172444444.444444
Gross profit: 855185185.1851851
Operating income: 347925925.9259259
Net income: -219481481.48148146
Capital expenditures: 2962962.9629629627
Operating cash flow: 419925925.9259259
Depreciation & amortization: 277629629.6296296
Net tangible assets: 705925925.9259259
Owner earnings: 55185185.18518519
Capex to operating income (%): 0.8516074089844582
Buffett classification: The Great
Stock price: 20.566176470588232
Shares outstanding: 321579686
Book value: 3187111111.111111
P/B ratio: 2.07512833442655
Market cap (USD): 6613664571.632352
Debt to equity: 0.7145214521452145
Current ratio: 0.8507886702849389
Quick ratio: 0.6075729308005428
Interest coverage ratio: 2.606548279689234
COGS to revenue (%): 73.04333613523863
R&D to revenue (%): 3.497711777341926
SG&A to revenue (%): 12.491827776221164
Free cash flow (dilution-adjusted): 55111111.111111104
Buyback yield (%): 0
Retained earnings: 1305629629.6296296
Inventory turnover: 5.453800557880056
Receivables turnover: 3.5761523046092183
Capitalized R&D asset: 174985185.1851852
ROCI (R&D-adjusted, %): 6.827949250922487
Rosenberg metric: 0.5503875968992237
FCF margin (%): 1.7371812832726252
Revenue growth (%): 6.787014411808707
Rule of 40 score: 8.524195695081332
Financial ratios for CAE.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.807407407407407
Shares outstanding: 321579686
Market cap (USD): 6048080168.548148
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAE.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 25.524475524475527
Shares outstanding: 321579686
Market cap (USD): 8208152824.475525
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAE.TO — quarterly report dated 2025-03-31
Total revenue: 891888111.888112
Gross profit: 273216783.2167832
Operating income: 143496503.4965035
Net income: 96643356.64335665
Capital expenditures: 11258741.25874126
Operating cash flow: 225664335.66433567
Depreciation & amortization: 77272727.27272728
Net tangible assets: 713636363.6363636
Owner earnings: 162657342.65734267
Return on net tangible assets (%): 22.792748652621267
Capex to operating income (%): 7.8460038986354785
Buffett classification: The Great
Stock price: 24.741258741258743
P/E ratio: 20.58156528704776
Shares outstanding: 321579686
Book value: 3479720279.7202797
P/B ratio: 2.2864729281913183
Market cap (USD): 7956286217.258742
Debt to equity: 0.697427652733119
Current ratio: 0.7979155034431417
Quick ratio: 0.5764377442769403
Effective tax rate (%): 24.645583424209377
Interest coverage ratio: 3.976744186046512
COGS to revenue (%): 69.36647326328995
R&D to revenue (%): 1.6779049709894935
SG&A to revenue (%): 12.866551670064293
Free cash flow (dilution-adjusted): 135874125.87412587
Buyback yield (%): 0
Retained earnings: 1477482517.4825175
Inventory turnover: 1.4868907563025209
Receivables turnover: 1.10596600763094
Capitalized R&D asset: 14965034.965034965
ROCI (R&D-adjusted, %): 2.567251940840907
FCF margin (%): 15.234436255292454
Rule of 40 score: 15.234436255292454
Financial ratios for CAE.TO — annual report dated 2025-03-31
Total revenue: 3292237762.2377625
Gross profit: 909160839.1608392
Operating income: 427622377.62237763
Net income: 290209790.2097902
Capital expenditures: 13566433.566433568
Operating cash flow: 626923076.923077
Depreciation & amortization: 290000000
Net tangible assets: 713636363.6363636
Owner earnings: 566643356.6433567
Return on net tangible assets (%): 79.40225379715827
Capex to operating income (%): 3.172526573998365
Buffett classification: The Great
Stock price: 24.741258741258743
P/E ratio: 27.41563684501205
Shares outstanding: 321579686
Book value: 3479720279.7202797
P/B ratio: 2.2864729281913183
Market cap (USD): 7956286217.258742
Debt to equity: 0.697427652733119
Current ratio: 0.7979155034431417
Quick ratio: 0.5764377442769403
Effective tax rate (%): 19.213548763869962
Interest coverage ratio: 3.1536874677668902
COGS to revenue (%): 72.38471505342085
R&D to revenue (%): 2.6168780135516894
SG&A to revenue (%): 12.009600883621149
Free cash flow (dilution-adjusted): 298741258.74125874
Buyback yield (%): 0.18721177806291706
Retained earnings: 1477482517.4825175
Inventory turnover: 5.7273949579831935
Receivables turnover: 4.0824661810613945
Capitalized R&D asset: 192032364.67236468
ROCI (R&D-adjusted, %): 6.762090170835059
Rosenberg metric: 0.4864294583920766
FCF margin (%): 9.074109475562352
Revenue growth (%): 3.776057229405522
Rule of 40 score: 12.850166704967874
Financial ratios for CAE.TO — quarterly report dated 2025-06-30
Total revenue: 801897810.218978
Gross profit: 225036496.35036495
Operating income: 81897810.21897809
Net income: 43941605.83941606
Capital expenditures: 3722627.737226277
Operating cash flow: -11167883.21167883
Depreciation & amortization: 82992700.729927
Net tangible assets: 859708029.1970803
Owner earnings: 123211678.83211678
Return on net tangible assets (%): 14.331805060281882
Capex to operating income (%): 4.545454545454546
Buffett classification: The Great
Stock price: 29.131386861313864
P/E ratio: 66.63630358583907
Shares outstanding: 321579686
Book value: 3643138686.1313868
P/B ratio: 2.571426192274248
Market cap (USD): 9368062239.605839
Debt to equity: 0.6826751617879826
Current ratio: 0.8655538694992413
Quick ratio: 0.5983091263819641
Effective tax rate (%): 23.98989898989899
Interest coverage ratio: 2.3229813664596275
COGS to revenue (%): 71.93701074094302
R&D to revenue (%): 3.340615328600036
SG&A to revenue (%): 14.509375568905881
Free cash flow (dilution-adjusted): -119781021.89781022
Buyback yield (%): 0
Retained earnings: 1598248175.1824815
Inventory turnover: 1.2821219987021415
Receivables turnover: 1.006043956043956
Capitalized R&D asset: 36814894.594456635
ROCI (R&D-adjusted, %): 1.505718528829512
Rosenberg metric: -3.2195238420083236
FCF margin (%): -14.937192790824689
Revenue growth (%): -10.089864465019717
Rule of 40 score: -25.027057255844404
Financial ratios for CAE.TO — quarterly report dated 2025-09-30
Total revenue: 889640287.7697842
Gross profit: 229712230.21582735
Operating income: 96402877.69784173
Net income: 54748201.43884893
Capital expenditures: 0
Operating cash flow: 153956834.5323741
Depreciation & amortization: 82014388.48920864
Net tangible assets: 940287769.7841728
Owner earnings: 136762589.92805755
Return on net tangible assets (%): 14.544758990053555
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 29.64748201438849
P/E ratio: 48.80905917595884
Shares outstanding: 321579686
Book value: 3712230215.8273387
P/B ratio: 2.568274972879845
Market cap (USD): 9534027956.877699
Debt to equity: 0.6521705426356589
Current ratio: 0.8345738589890398
Quick ratio: 0.5945525928349419
Effective tax rate (%): 22.66260162601626
Interest coverage ratio: 2.3550087873462213
COGS to revenue (%): 74.17920103509623
R&D to revenue (%): 2.9920750444767914
SG&A to revenue (%): 11.992560245835355
Free cash flow (dilution-adjusted): 71870503.59712231
Buyback yield (%): 0.017355479409929233
Retained earnings: 1641582733.8129497
Inventory turnover: 1.5629579144658374
Receivables turnover: 1.0468128333192246
Capitalized R&D asset: 49505341.75691451
ROCI (R&D-adjusted, %): 1.599145408705694
Rosenberg metric: 0.1745437437515934
FCF margin (%): 8.078602620087336
Revenue growth (%): 10.941852743910836
Rule of 40 score: 19.020455363998174
Financial ratios for CAE.TO — quarterly report dated 2025-12-31
Total revenue: 913941605.839416
Gross profit: 264379562.0437956
Operating income: 127372262.77372262
Net income: 81824817.51824817
Capital expenditures: 0
Operating cash flow: 297518248.17518246
Depreciation & amortization: 84306569.3430657
Net tangible assets: 1065766423.3576641
Owner earnings: 166131386.86131388
Return on net tangible assets (%): 15.587973426477642
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 30.467153284671532
P/E ratio: 35.35029926144906
Shares outstanding: 321579686
Book value: 3832116788.321167
P/B ratio: 2.55671163688381
Market cap (USD): 9797617586.59854
Debt to equity: 0.6182857142857143
Current ratio: 0.9144416705454238
Quick ratio: 0.6910675750010579
Effective tax rate (%): 20.889202540578687
Interest coverage ratio: 3.22550831792976
COGS to revenue (%): 71.0725980353007
R&D to revenue (%): 2.0765114607459467
SG&A to revenue (%): 12.914303969331522
Free cash flow (dilution-adjusted): 247372262.77372262
Buyback yield (%): 0.0119200734398564
Retained earnings: 1748467153.2846713
Inventory turnover: 1.6857359348361431
Receivables turnover: 1.1775604250916958
Capitalized R&D asset: 45652780.5492832
ROCI (R&D-adjusted, %): 1.919164615014959
Rosenberg metric: 1.3023673308344825
FCF margin (%): 27.066528232569283
Revenue growth (%): 2.7315892056273836
Rule of 40 score: 29.798117438196666
Financial ratios for CAPLIPOINT.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.781616774363709
Shares outstanding: 76011696
Market cap (USD): 667505584.6414348
Buyback yield (%): 0
Retained earnings: 157088223.65818277
Capitalized R&D asset: 7816167.743637083
Rule of 40 score: 0
Financial ratios for CAPLIPOINT.NS — annual report dated 2023-03-31
Total revenue: 177079171.74177834
Gross profit: 95560292.32643119
Operating income: 48521315.46894032
Net income: 45918392.204628505
Capital expenditures: 23565164.43361754
Operating cash flow: 33053593.179049943
Depreciation & amortization: 5479902.557856273
Net tangible assets: 227686967.1132765
Owner earnings: 27833130.328867234
Return on net tangible assets (%): 12.224296665614585
Capex to operating income (%): 48.566623154935236
Buffett classification: The Good
Stock price: 7.165651644336175
P/E ratio: 11.8617684174116
Shares outstanding: 76011696
Book value: 232310596.83313036
P/B ratio: 2.3445909995333643
Market cap (USD): 544673334.4311814
Debt to equity: 0.002873216691920913
Current ratio: 5.791753731343284
Quick ratio: 4.716305970149254
Effective tax rate (%): 16.475019386285588
Interest coverage ratio: 510.7179487179487
COGS to revenue (%): 46.03527259220536
R&D to revenue (%): 4.346480307053143
SG&A to revenue (%): 2.6612648058219035
Free cash flow (dilution-adjusted): 8856272.838002438
Buyback yield (%): 0
Retained earnings: 187550548.1120585
Inventory turnover: 2.322080355284158
Receivables turnover: 3.6893366492412323
Capitalized R&D asset: 12933543.715886055
ROCI (R&D-adjusted, %): 20.649371477217617
FCF margin (%): 5.001306901817282
Rule of 40 score: 5.001306901817282
Financial ratios for CAPLIPOINT.NS — annual report dated 2024-03-31
Total revenue: 201409041.85154095
Gross profit: 113947715.55342367
Operating income: 59719390.81424631
Net income: 55332773.71387456
Capital expenditures: 17486509.17376184
Operating cash flow: 38180837.03081904
Depreciation & amortization: 6408442.259263701
Net tangible assets: 276194987.4085622
Owner earnings: 44254706.79937643
Return on net tangible assets (%): 16.022994195007794
Capex to operating income (%): 29.281124497991968
Buffett classification: The Good
Stock price: 15.654390595009598
P/E ratio: 21.504737592338696
Shares outstanding: 76011696
Book value: 281428228.80441296
P/B ratio: 4.228135834234657
Market cap (USD): 1189916778.9731288
Debt to equity: 0.0008394302101132166
Current ratio: 5.72138431313284
Quick ratio: 4.624089466525616
Effective tax rate (%): 18.250270184079515
Interest coverage ratio: 638.4615384615385
COGS to revenue (%): 43.42472686136168
R&D to revenue (%): 4.389270935667292
SG&A to revenue (%): 2.483403292548599
Free cash flow (dilution-adjusted): 20592397.169924453
Buyback yield (%): 0
Retained earnings: 235365151.69684616
Inventory turnover: 2.008979726751873
Receivables turnover: 3.094689711084906
Capitalized R&D asset: 16576520.480720866
ROCI (R&D-adjusted, %): 20.116771545682784
Rosenberg metric: 2.388997383978609
FCF margin (%): 10.224167187639548
Revenue growth (%): 13.739543657478299
Rule of 40 score: 23.963710845117845
Financial ratios for CAPLIPOINT.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 302300525.5613951
Buffett classification: The Gruesome
Stock price: 22.56366459627329
Shares outstanding: 76011696
Book value: 307525083.6120401
P/B ratio: 5.577113885453275
Market cap (USD): 1715102413.9378881
Debt to equity: 0.0009438359356793289
Current ratio: 6.0669580525708735
Quick ratio: 5.074151642080981
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAPLIPOINT.NS — quarterly report dated 2024-12-31
Total revenue: 57461242.56906399
Gross profit: 34690523.37102226
Operating income: 17028791.234409604
Net income: 16327077.747989275
Capital expenditures: 0
Depreciation & amortization: 1888331.9734234759
Owner earnings: 18215409.72141275
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 29.011539806504253
P/E ratio: 33.76624369500964
Shares outstanding: 76011696
Market cap (USD): 2205216344.2639003
Effective tax rate (%): 20.98048064989281
Interest coverage ratio: 811.6111111111112
COGS to revenue (%): 39.62796170074651
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAPLIPOINT.NS — quarterly report dated 2025-03-31
Total revenue: 58738601.8237082
Gross profit: 35217442.132335745
Operating income: 17654898.293196164
Net income: 16983867.196633153
Capital expenditures: 0
Depreciation & amortization: 1992050.5026888005
Net tangible assets: 331416880.99134904
Owner earnings: 18975917.69932195
Return on net tangible assets (%): 5.725694370956704
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 23.228031275528068
P/E ratio: 25.98939969843766
Shares outstanding: 76011696
Book value: 337303016.1328033
P/B ratio: 5.234468615895143
Market cap (USD): 1765602051.9939318
Debt to equity: 0.0017398597714614477
Current ratio: 6.965043410144265
Quick ratio: 5.868039689274757
Effective tax rate (%): 17.7675892907681
Interest coverage ratio: 888.3529411764705
COGS to revenue (%): 40.043785451288684
Buyback yield (%): 0
Retained earnings: 276941781.6226327
Inventory turnover: 0.5986313597143708
Receivables turnover: 0.7943999114610508
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.204947836786181
Revenue growth (%): 2.2229927469962387
Rule of 40 score: 2.2229927469962387
Financial ratios for CAPLIPOINT.NS — annual report dated 2025-03-31
Total revenue: 226498714.0519055
Gross profit: 136384147.76712647
Operating income: 67917933.13069908
Net income: 63255786.76642506
Capital expenditures: 22389525.368248772
Operating cash flow: 50545943.41828384
Depreciation & amortization: 7711012.391863455
Net tangible assets: 331416880.99134904
Owner earnings: 48577273.79003973
Return on net tangible assets (%): 14.657453067789792
Capex to operating income (%): 32.96555760194158
Buffett classification: The Good
Stock price: 23.228031275528068
P/E ratio: 27.91210325963535
Shares outstanding: 76011696
Book value: 337431610.94224924
P/B ratio: 5.232473765761415
Market cap (USD): 1765602051.9939318
Debt to equity: 0.001739196712848922
Current ratio: 6.965043410144265
Quick ratio: 5.868039689274757
Effective tax rate (%): 20.049351340169626
Interest coverage ratio: 952.4098360655738
COGS to revenue (%): 39.785906362421095
R&D to revenue (%): 3.957738700470201
SG&A to revenue (%): 4.052707912896715
Free cash flow (dilution-adjusted): 27059855.038578443
Buyback yield (%): 0
Retained earnings: 276941781.6226327
Inventory turnover: 2.2934840821184173
Receivables turnover: 3.0632421065945707
Capitalized R&D asset: 17427202.319206934
ROCI (R&D-adjusted, %): 19.167948291333644
Rosenberg metric: 2.537946394873408
FCF margin (%): 11.947023695850776
Revenue growth (%): 12.457073411261353
Rule of 40 score: 24.40409710711213
Financial ratios for CAPLIPOINT.NS — quarterly report dated 2025-06-30
Total revenue: 59702784.92862158
Gross profit: 36857009.127077
Operating income: 18894219.517903116
Net income: 17879709.80575708
Capital expenditures: 0
Depreciation & amortization: 1906154.9262813013
Owner earnings: 19785864.73203838
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 24.696700210624854
P/E ratio: 36.67149947128261
Shares outstanding: 76011696
Market cap (USD): 1877238068.6131525
Effective tax rate (%): 18.269543532473165
Interest coverage ratio: 897.0555555555557
COGS to revenue (%): 38.265846105601504
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 1.641481198015541
Rule of 40 score: 1.641481198015541
Financial ratios for CAPLIPOINT.NS — quarterly report dated 2025-12-31
Total revenue: 60462292.52534255
Gross profit: 36496602.42842821
Operating income: 18982956.444246408
Net income: 18476105.6032082
Capital expenditures: 0
Depreciation & amortization: 2147710.8165311352
Owner earnings: 20623816.419739336
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 20.435223348557425
P/E ratio: 22.296371712692338
Shares outstanding: 76011696
Market cap (USD): 1553315984.862649
Effective tax rate (%): 18.652214429349158
Interest coverage ratio: 946.7222222222223
COGS to revenue (%): 39.63741547985334
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 1.2721476856213703
Rule of 40 score: 1.2721476856213703
Financial ratios for CHMG — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 243000
Buffett classification: The Gruesome
Stock price: 41.16
Shares outstanding: 4819820
Market cap (USD): 198383791.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHMG — annual report dated 2022-12-31
Total revenue: 94614000
Net income: 28783000
Capital expenditures: 426000
Operating cash flow: 35047000
Depreciation & amortization: 3026000
Net tangible assets: 144564000
Owner earnings: 31383000
Return on net tangible assets (%): 21.708724163692207
Buffett classification: The Gruesome
Stock price: 41.8
P/E ratio: 6.99956488204843
Shares outstanding: 4819820
Book value: 166388000
P/B ratio: 1.2108353727432264
Market cap (USD): 201468476
Debt to equity: 0.6356047311104166
Effective tax rate (%): 21.97403019870422
COGS to revenue (%): 0
SG&A to revenue (%): 35.27067875790052
Free cash flow (dilution-adjusted): 33826000
Buyback yield (%): 0.46309974568924617
Retained earnings: 211859000
Receivables turnover: 1.591301276552803
Capitalized R&D asset: 0
FCF margin (%): 35.75158010442429
Rule of 40 score: 35.75158010442429
Financial ratios for CHMG — annual report dated 2023-12-31
Total revenue: 97959000
Net income: 25000000
Capital expenditures: 462000
Operating cash flow: 30881000
Depreciation & amortization: 2802000
Net tangible assets: 173417000
Owner earnings: 27340000
Return on net tangible assets (%): 15.765467053403068
Buffett classification: The Gruesome
Stock price: 46.7
P/E ratio: 9.00342376
Shares outstanding: 4819820
Book value: 195241000
P/B ratio: 1.1528602803714385
Market cap (USD): 225085594
Debt to equity: 0.20895713502799104
Effective tax rate (%): 20.63744008126726
COGS to revenue (%): 0
SG&A to revenue (%): 37.337049173633865
Free cash flow (dilution-adjusted): 29280000
Buyback yield (%): 0.14039103719805365
Retained earnings: 229930000
Capitalized R&D asset: 0
FCF margin (%): 29.890056043855083
Revenue growth (%): 3.5354175914769486
Rule of 40 score: 33.42547363533203
Financial ratios for CHMG — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 46
Shares outstanding: 4819820
Market cap (USD): 221711720
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHMG — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 47.04
Shares outstanding: 4819820
Market cap (USD): 226724332.79999998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHMG — annual report dated 2024-12-31
Total revenue: 96107000
Net income: 23671000
Capital expenditures: 3582000
Operating cash flow: 29815000
Depreciation & amortization: 2016000
Net tangible assets: 193485000
Owner earnings: 22105000
Return on net tangible assets (%): 11.424658242241001
Buffett classification: The Gruesome
Stock price: 47.04
P/E ratio: 9.578147640572853
Shares outstanding: 4819820
Book value: 215309000
P/B ratio: 1.0530183726644033
Market cap (USD): 226724332.79999998
Debt to equity: 0.5504553920179834
Effective tax rate (%): 21.31959448230015
COGS to revenue (%): 0
SG&A to revenue (%): 40.51005649952657
Free cash flow (dilution-adjusted): 24951000
Buyback yield (%): 0.1517261053331458
Retained earnings: 247705000
Capitalized R&D asset: 0
FCF margin (%): 25.96168853465408
Revenue growth (%): -1.8905868781837298
Rule of 40 score: 24.07110165647035
Financial ratios for CHMG — quarterly report dated 2025-03-31
Total revenue: 25428000
Net income: 6023000
Capital expenditures: 328000
Operating cash flow: 7180000
Depreciation & amortization: 661000
Net tangible assets: 206482000
Owner earnings: 6356000
Return on net tangible assets (%): 3.078234422370957
Buffett classification: The Gruesome
Stock price: 46.15
P/E ratio: 9.23272011456085
Shares outstanding: 4819820
Book value: 228306000
P/B ratio: 0.974283168204077
Market cap (USD): 222434693
Debt to equity: 0.412678598021953
Effective tax rate (%): 21.646936386106415
COGS to revenue (%): 0
SG&A to revenue (%): 38.52446122384773
Free cash flow (dilution-adjusted): 6558000
Buyback yield (%): 0.03821346340069352
Retained earnings: 252195000
Capitalized R&D asset: 0
FCF margin (%): 25.790467201510147
Rule of 40 score: 25.790467201510147
Financial ratios for CHMG — quarterly report dated 2025-06-30
Total revenue: 9807000
Net income: -6356000
Capital expenditures: 940000
Operating cash flow: 9746000
Depreciation & amortization: 587000
Net tangible assets: 213142000
Owner earnings: -6709000
Return on net tangible assets (%): -3.1476668136735135
Buffett classification: The Gruesome
Stock price: 47.34
Shares outstanding: 4819820
Book value: 234966000
P/B ratio: 0.9710778529659612
Market cap (USD): 228170278.8
Debt to equity: 0.4599857000587319
COGS to revenue (%): 0
SG&A to revenue (%): 106.82165799938818
Free cash flow (dilution-adjusted): 9039000
Buyback yield (%): 0.0021913458783046373
Retained earnings: 244211000
Capitalized R&D asset: 0
FCF margin (%): 92.16885897828082
Revenue growth (%): -61.43227937706466
Rule of 40 score: 30.736579601216164
Financial ratios for CHMG — quarterly report dated 2025-09-30
Total revenue: 28514000
Net income: 7792000
Capital expenditures: 377000
Operating cash flow: 12240000
Depreciation & amortization: 657000
Net tangible assets: 223484000
Owner earnings: 8072000
Return on net tangible assets (%): 3.611891679046374
Buffett classification: The Gruesome
Stock price: 51.63
P/E ratio: 33.362019922241586
Shares outstanding: 4819820
Book value: 245308000
P/B ratio: 1.014428011316386
Market cap (USD): 248847306.60000002
Debt to equity: 0.2146525999967388
Effective tax rate (%): 22.59858945068044
COGS to revenue (%): 0
SG&A to revenue (%): 37.7989759416427
Free cash flow (dilution-adjusted): 11501000
Buyback yield (%): 0.0044203813777585
Retained earnings: 250373000
Capitalized R&D asset: 0
FCF margin (%): 40.33457249070632
Revenue growth (%): 190.75150402773528
Rule of 40 score: 231.0860765184416
Financial ratios for CHMG — quarterly report dated 2025-12-31
Total revenue: 30201000
Net income: 7843000
Capital expenditures: 517000
Operating cash flow: 16333000
Depreciation & amortization: 761000
Net tangible assets: 232885000
Owner earnings: 8087000
Return on net tangible assets (%): 3.472529359984542
Buffett classification: The Gruesome
Stock price: 55.17
P/E ratio: 17.37743232257221
Shares outstanding: 4819820
Book value: 254709000
P/B ratio: 1.0439735910391859
Market cap (USD): 265909469.4
Debt to equity: 0.5477584223564931
Effective tax rate (%): 29.58246156645138
COGS to revenue (%): 0
SG&A to revenue (%): 35.121353597562994
Free cash flow (dilution-adjusted): 15268000
Buyback yield (%): 0.11094001302986317
Retained earnings: 256484000
Capitalized R&D asset: 0
FCF margin (%): 50.55461739677494
Revenue growth (%): 5.916391947815108
Rule of 40 score: 56.471009344590044
Financial ratios for CHMG — annual report dated 2025-12-31
Total revenue: 93950000
Net income: 15104000
Capital expenditures: 282000
Operating cash flow: 45499000
Depreciation & amortization: 2666000
Net tangible assets: 232885000
Owner earnings: 17488000
Return on net tangible assets (%): 7.5092856989501255
Buffett classification: The Gruesome
Stock price: 55.17
P/E ratio: 17.605234997351698
Shares outstanding: 4819820
Book value: 254709000
P/B ratio: 1.0439735910391859
Market cap (USD): 265909469.4
Debt to equity: 0.5477584223564931
Effective tax rate (%): 24.23756019261637
COGS to revenue (%): 0
SG&A to revenue (%): 44.4598190526876
Free cash flow (dilution-adjusted): 42366000
Buyback yield (%): 0.14892286494856208
Retained earnings: 256484000
Capitalized R&D asset: 0
FCF margin (%): 45.09419904204364
Revenue growth (%): -2.2443734587491027
Rule of 40 score: 42.84982558329454
Financial ratios for CMRC — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 35.37
Shares outstanding: 82512244
Market cap (USD): 2918458070.2799997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMRC — annual report dated 2022-12-31
Total revenue: 279075000
Gross profit: 209095000
Operating income: -98019000
Net income: -139919000
Capital expenditures: 5196000
Operating cash flow: -89357000
Depreciation & amortization: 11421000
Net tangible assets: -31660000
Owner earnings: -133694000
Buffett classification: The Gruesome
Stock price: 8.74
Shares outstanding: 82512244
Book value: 45672000
P/B ratio: 15.789915321422315
Market cap (USD): 721157012.5600001
Debt to equity: 7.66583464704852
Current ratio: 4.75017135023989
Quick ratio: 4.75017135023989
Interest coverage ratio: -112.92511520737327
COGS to revenue (%): 25.07569649735734
R&D to revenue (%): 31.623398727940515
SG&A to revenue (%): 75.52915882827197
Free cash flow (dilution-adjusted): -136885000
Buyback yield (%): 0
Retained earnings: -529987000
Receivables turnover: 7.957202326642336
Capitalized R&D asset: 88253000
ROCI (R&D-adjusted, %): -8.10378548004266
FCF margin (%): -49.04953865448356
Rule of 40 score: -49.04953865448356
Financial ratios for CMRC — annual report dated 2023-12-31
Total revenue: 309394000
Gross profit: 235192000
Operating income: -55758000
Net income: -64671000
Capital expenditures: 4179000
Operating cash flow: -24243000
Depreciation & amortization: 12480000
Net tangible assets: -53605000
Owner earnings: -56370000
Buffett classification: The Gruesome
Stock price: 9.73
Shares outstanding: 82512244
Book value: 25533000
P/B ratio: 31.443392242196378
Market cap (USD): 802844134.12
Debt to equity: 13.698586143422238
Current ratio: 4.833724381625442
Quick ratio: 4.833724381625442
Interest coverage ratio: -62.369127516778526
COGS to revenue (%): 23.983011952397266
R&D to revenue (%): 26.9753130312805
SG&A to revenue (%): 64.34126065793131
Free cash flow (dilution-adjusted): -69607000
Buyback yield (%): 0
Retained earnings: -594658000
Receivables turnover: 8.203908466576513
Capitalized R&D asset: 142589510
ROCI (R&D-adjusted, %): -5.725103551414052
Rosenberg metric: 0.29570666152991965
FCF margin (%): -22.497850637051787
Revenue growth (%): 10.864104631371495
Rule of 40 score: -11.633746005680292
Financial ratios for CMRC — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.85
Shares outstanding: 82512244
Market cap (USD): 482696627.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMRC — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.12
Shares outstanding: 82512244
Market cap (USD): 504974933.28000003
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMRC — annual report dated 2024-12-31
Total revenue: 332927000
Gross profit: 255338000
Operating income: -26673000
Net income: -27030000
Capital expenditures: 3721000
Operating cash flow: 26254000
Depreciation & amortization: 13811000
Net tangible assets: -35875000
Owner earnings: -16940000
Buffett classification: The Gruesome
Stock price: 6.12
Shares outstanding: 82512244
Book value: 33369000
P/B ratio: 15.133055628877102
Market cap (USD): 504974933.28000003
Debt to equity: 6.610446821900567
Current ratio: 2.8545667340863123
Quick ratio: 2.8545667340863123
Interest coverage ratio: -5.224877571008815
COGS to revenue (%): 23.305108927782967
R&D to revenue (%): 24.293313549216496
SG&A to revenue (%): 57.48887894343204
Free cash flow (dilution-adjusted): -12844000
Buyback yield (%): 0
Retained earnings: -621688000
Receivables turnover: 6.919113826714051
Capitalized R&D asset: 165920690
ROCI (R&D-adjusted, %): -7.171465496474536
Rosenberg metric: 0.2413850946561227
FCF margin (%): -3.8579027834930777
Revenue growth (%): 7.60615913689341
Rule of 40 score: 3.7482563534003326
Financial ratios for CMRC — quarterly report dated 2025-03-31
Total revenue: 82370000
Gross profit: 65386000
Operating income: -165000
Net income: -353000
Capital expenditures: 825000
Operating cash flow: 401000
Depreciation & amortization: 4281000
Net tangible assets: -31278000
Owner earnings: 3103000
Buffett classification: The Gruesome
Stock price: 5.76
Shares outstanding: 82512244
Book value: 38075000
P/B ratio: 12.482482611687459
Market cap (USD): 475270525.44
Debt to equity: 4.380512147078135
Current ratio: 2.342557019890094
Quick ratio: 2.342557019890094
Effective tax rate (%): 306.4327485380117
Interest coverage ratio: -0.05982596084118927
COGS to revenue (%): 20.619157460240377
R&D to revenue (%): 23.316741532111205
SG&A to revenue (%): 53.4296467160374
Free cash flow (dilution-adjusted): -8077000
Buyback yield (%): 0
Retained earnings: -622041000
Receivables turnover: 1.8650937415089213
Capitalized R&D asset: 19206000
ROCI (R&D-adjusted, %): 5.6615690595855614
FCF margin (%): -9.805754522277528
Rule of 40 score: -9.805754522277528